Abiret 250 Mg (Abiraterone) – 7 Tablets
$ 100.00
Abiret 250 Mg (Abiraterone) is used in men whose prostate cancer cannot be treated with surgery or other medicines. Abiret 250 Mg a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with
- Metastatic castration-resistant prostate cancer (CRPC).
- Metastatic high-risk castration-sensitive prostate cancer (CSPC).
- Hormone-refractory or hormone-resistant prostate cancer.
- It is also used with methylprednisolone for patients whose cancer is castrate-resistant.
Abiraterone tablets should not be handled by a woman who is pregnant or who may become pregnant. This medicine can harm an unborn baby or cause miscarriage.
Product Feature:
Manufacturer | : Drug International Ltd. |
Indication | : Prostate Cancer. |
Generic | : Abiraterone Acetate |
Formulation | : Tablets |
Pack Size | : 7 Tablets |
Strengths | : 250 Mg |
Storage | : Below 30°C |
Essential medications for prostate cancer, such as Abiret 250 Mg (Abiraterone), can be procured from Unit Pharmacy!
Reviews
There are no reviews yet.